Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Merck Serono Sets Plan For Europe
by Ann M. Thayer
June 25, 2012
| A version of this story appeared in
Volume 90, Issue 26
After negotiating with employees, Merck Serono has finalized its plan for consolidating operations in Europe. In Switzerland, it will close its Geneva site by mid-2013 and its Coinsins location in 2014, transferring about 750 employees and eliminating 500 jobs. The company will continue to employ about 1,000 people at three other Swiss sites. Headquarters functions in Geneva will move to Darmstadt, Germany, and manufacturing in Coinsins will move to Aubonne, Switzerland. R&D will be focused in Darmstadt, Boston, and Beijing. Merck is offering up to $38 million in support for firms started by former employees.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter